BIOPROCESSING OPERATIONS RECORDS 3 CONSECUTIVE QUARTERS OF REVENUE GROWTH OPERATIONAL EFFICIENCIES CUT QUARTER AND YTD NET LOSSES BY 46% AND 34% TWO MAJOR NEW PRODUCTS TO LAUNCH IN Q1 2025 Investor Ca ...

The medical device maker's adjusted earnings per share and revenue were more than expected, as sales of its cardiovascular products ... Scientific Lowers FY EPS Outlook, Raises Adjusted EPS The ...